<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Sandostatin LAR; Octreotide" /><meta name="IX" content="Sandostatin LAR; Octreotide" /><title>Sandostatin Lar®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../383/theme.css" /><link type="text/css" rel="stylesheet" href="204/style.css" /><link type="image/x-icon" rel="shortcut icon" href="../../favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5811-sandostatin-lar.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js"></script><script type="text/javascript" src="../../383/scripts.js"></script><style type="text/css">
          .contentsbox { position: fixed; z-index:1001; }
          .contentsbox_wrap { overflow: hidden; width: 20px; height: 130px; position: absolute; left: 0; top: 0; }
        </style><!--[if IE 8]>
          <style type="text/css">
          #p1 {
          float: left;
          padding-bottom: 15em;
          }
          </style>
          <![endif]--><!--[if lte IE 8]>
          <style type="text/css">
          #start-search input {
          height: 28px;
          padding-top: 8px;
          }
          @media screen {
          #pV {
          display: block !important;
          }
          }
          </style>
          <![endif]--><!--[if IE 7]>
          <style type="text/css">
          #start-search input {
          position: absolute !important;
          left: 0;
          top: 0;
          }
          .as-shadow {
          margin-left: -4px !important;
          color: silver;
          }
          </style>
          <![endif]--><!--[if lte IE 7]>
          <style type="text/css">
          .menu {
          height: 1%;
          }
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }

          #account-info ul li a {
          width: 12em;
          }
          #opts ul li span {
          width: 12em;
          }
          div.as-select ul li ul li span {
          width: 40em;
          }
          div.menu ul li ul li {
          float: left !important;
          }
          #pQ fieldset, #qd, #input-box, #pub-list, #start-search, #end-search {
          display: inline;
          float: left;
          height: 100%;
          padding: 0;
          margin: 0;
          position: relative;
          }
          #hM a, #hM a img {
          border: none;
          display: inline-block;
          float: left;
          }
          #qd input {
          float: left;
          display: inline-block !important;
          }
          #start-search input {
          height: 28px;
          padding-top: 8px !important;
          }
          #end-search, #end-search input {
          height: 36px !important;
          }
          #hM, #content, #searchForm, #purple-menu {
          width: expression(document.body.clientWidth > 63 * parseInt(document.body.currentStyle.fontSize) ? '63em': 'auto');
          margin: 0 auto;
          }
          #pQ {
          z-index: 1;
          }
          </style>
          <![endif]--><!--[if lte IE 6]>
          <style type="text/css">
          body {
          height: 100%;
          }
          div.menu ul li a, div.menu ul li span {
          display: inline-block;
          }
          div.menu ul li ul li {
          clear: both;
          }
          div.as-select ul li span {
          height: 20px;
          padding-top: 16px;
          padding-left: 1em;
          padding-bottom: 0;
          padding-left: 1em;
          margin: 4px 0;
          border-right: 1px solid #888;
          background-image: url("images/dropdown_img.png");
          background-repeat: repeat-x;
          overflow-x: hidden;
          }
          div.as-select ul li ul li span {
          font: bold 10px Verdana !important;
          padding: 4px 1em !important;
          color: #2D2D2D;
          background: white;
          text-decoration: none !important;
          white-space: nowrap;
          border: none !important;
          float: left;
          }
          div.menu span.hover {
          background: #8F1F8D;
          color: white;
          }
          </style>
          <![endif]--></head><body><!--[if lte IE 6]>
          <script type="text/javascript">
          jQuery(document).ready(function($) {
          $('a.mclogo').html('<img src="images/mc_logo.gif" class="logo" />');
          });
          </script>
          <![endif]--><?highlighter off?><div id="hC"><div id="vH"><div id="pU"><a class="mclogo" href="http://www.medicinescomplete.com/about/"><img class="logo" src="../../images/mc_logo.png" alt="MedicinesComplete" /></a><div id="hM"><div id="vM" class="menu"><ul><li><a href="http://www.medicinescomplete.com/mc/index.htm">Home</a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm">Help</a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5811-sandostatin-lar.htm">Feedback</a></li><li id="account-info"><a href="http://www.medicinescomplete.com/mc/account.htm">BNF.org Free Access</a><ul><li><a href="http://www.medicinescomplete.com/mc/account.htm">My Account</a></li><li><a href="http://www.medicinescomplete.com/mc/subscribe.htm">Subscribe</a></li><li><a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li><a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul></li></ul></div><a id="pD" accesskey="s" rel="bookmark" href="PHP5811-sandostatin-lar.htm#pB" title="Skip Navigation">Skip Navigation</a></div></div><div id="pA"><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 13 Mar 2013 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="search-in">Publication</label><label for="q">Search for</label><div id="qd"><div id="start-search"><div class="as-select menu" id="pub-list"><ul><li><span>British National Formulary</span><ul></ul></li></ul></div><div id="input-box"><input type="text" id="q" name="q" accesskey="4" /></div></div><div id="end-search"><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div></div></div><div id="pH"><div id="pN"><div id="pT"><!--[if lte IE 7]>
             
            <![endif]--><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF March 2013</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5728-sex-hormones-and-hormone-antagonists-in-malignant-disease.htm">8.3 Sex hormones and hormone antagonists in malignant disease</a> &gt; <a href="PHP5746-hormone-antagonists.htm">8.3.4 Hormone antagonists</a> &gt; <a href="PHP5801-somatostatin-analogues.htm">8.3.4.3 Somatostatin analogues</a> &gt; <a href="PHP5807-octreotide.htm">OCTREOTIDE</a> &gt; <a href="PHP5810-depot-preparation.htm">Depot preparation</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5804-lanreotide.htm" title="Previous: LANREOTIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP18715-pasireotide.htm" title="Next: PASIREOTIDE">Next page</a> ►</div></div></div></div><div id="content"><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a393049.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Other Miscellaneous Therapeutic Agents 92:92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/13510-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Octreotide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: O &gt; Interactions of Octreotide</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="PHP130-continuous-subcutaneous-infusions.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Continuous subcutaneous infusions</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="PHP5668-introna.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">IntronA®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.4 Other immunomodulating drugs &gt; Interferon alfa &gt; INTERFERON ALFA</p></div></li><li><a href="PHP5801-somatostatin-analogues.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.3.4.3 Somatostatin analogues</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.3 Sex hormones and hormone antagonists in malignant disease &gt; 8.3.4 Hormone antagonists</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22octreotide%22%22octreotide%22%22carcinoid+tumour%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13274-chronic-hypoglycaemia.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Chronic hypoglycaemia</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13278-octreotide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">OCTREOTIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia &gt; Chronic hypoglycaemia</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13279-sandostatin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sandostatin®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia &gt; Chronic hypoglycaemia &gt; OCTREOTIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22octreotide%22%22octreotide%22%22carcinoid+tumour%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1213.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a591005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0014s0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/o01-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16932-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Growth Hormone and its Modulators &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06762.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; O &gt; OC</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-O3.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; O</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-O4.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; O</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D270.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Octreotide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; O</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><?highlighter on?><h1>OCTREOTIDE</h1><?highlighter off?><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int584-octreotide.htm">Octreotide</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see under Dose</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: Somatostatin analogue cautions" href="PHP5801-somatostatin-analogues.htm#PHP5802">notes above</a>; monitor thyroid function on long-term therapy; monitor liver function; <strong>interactions:</strong> Appendix 1 (octreotide)</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">adjustment of maintenance dose of non-depot preparations may be necessary in patients with liver cirrhosis</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">possible effect on fetal growth; manufacturer advises use only if potential benefit outweighs risk and effective contraception required during treatment</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—present in milk in <em>animal</em> studies</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="sub-sub-section: Somatostatin analogues" href="PHP5801-somatostatin-analogues.htm">notes above</a>; also arrhythmias, bradycardia, dyspnoea, headache, dizziness, dehydration, alopecia, rash; hepatitis also reported</p></div></div><div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Symptoms associated with carcinoid tumours with features of carcinoid syndrome, VIPomas, glucagonomas, <span class="cK">by subcutaneous injection</span>, initially 50 micrograms once or twice daily, gradually increased according to response to 200 micrograms 3 times daily (higher doses required exceptionally); maintenance doses variable; in carcinoid tumours discontinue after 1 week if no effect; if rapid response required, initial dose <span class="cK">by intravenous injection</span> (with ECG monitoring and after dilution to a concentration of 10–50% with sodium chloride 0.9% injection)</p></li><li><p>Acromegaly, short-term treatment before pituitary surgery <em>or</em> long-term treatment in those inadequately controlled by other treatment <em>or</em> until radiotherapy becomes fully effective <span class="cK">by subcutaneous injection</span>, 100–200 micrograms 3 times daily; discontinue if no improvement within 3 months</p></li><li><p>Prevention of complications following pancreatic surgery, consult product literature</p></li></ul></div></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP5808-octreotide-non-proprietary.htm#PHP5808-octreotide-non-proprietary" title="Octreotide">Octreotide</a></li><li><a href="PHP5809-sandostatin.htm#PHP5809-sandostatin" title="Sandostatin®">Sandostatin®</a></li></ul><div id="PHP5810-depot-preparation" style="margin: 0 0 0 20px;"><h1 class="title">Depot preparation</h1><div id="PHP5811-sandostatin-lar" style="margin: 0 0 0 20px;"><h1 class="title">Sandostatin Lar® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10261">Novartis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Injection</strong>  (microsphere powder for aqueous suspension), octreotide (as acetate) 10-mg vial = £427.13; 20-mg vial = £705.50; 30-mg vial = £903.13 (all supplied with 2.5-mL diluent-filled syringe)</p><p class="cR"><strong>Dose </strong>acromegaly (test dose <span class="cK">by subcutaneous injection</span> 50–100 micrograms if subcutaneous octreotide not previously given), neuroendocrine (particularly carcinoid) tumour adequately controlled by subcutaneous octreotide, <span class="cK">by deep intramuscular injection</span> into gluteal muscle, initially 20 mg every 4 weeks for 3 months then adjusted according to response; max. 30 mg every 4 weeks</p><p class="cR">For acromegaly, start depot octreotide 1 day after the last dose of subcutaneous octreotide (for pituitary surgery give last dose of depot octreotide at least 3 weeks before surgery); for neuroendocrine tumours, continue subcutaneous octreotide for 2 weeks after first dose of depot octreotide </p><p class="cR">Advanced neuroendocrine tumours of the midgut, or tumours of unknown primary origin where non-midgut sites of origin have been excluded, 30 mg every 4 weeks</p></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5804-lanreotide.htm">Previous: LANREOTIDE</a> | <a class="top" href="PHP5811-sandostatin-lar.htm#">Top</a> | <a accesskey="]" href="PHP18715-pasireotide.htm">Next: PASIREOTIDE</a> ►</div></div></div></div><div id="pF"><div id="p2"><div id="pL"><div class="p4"><h2>Keep in touch</h2><ul><li><a href="http://www.pharmpress.com/?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Pharmaceutical Press</a></li><li><a href="http://www.rpharms.com/">Royal Pharmaceutical Society</a></li><li><a href="http://www.pharmpress.com/mc-alerts.asp?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Sign up for our eNewsletter</a></li><li><a href="http://twitter.com/#!/PharmPress/" class="p5"><img src="../../images/twitter.png" alt="Twitter logo" />Follow us on Twitter
              </a></li><li><a href="http://www.facebook.com/pages/Pharmaceutical-Press/296104187066918" class="p5"><img src="../../images/facebook.png" alt="Facebook logo" />Find us on Facebook
              </a></li></ul></div><div class="p4"><h2>Help and Support</h2><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a></li><li><a href="http://www.medicinescomplete.com/about/contact.htm">Contact Us</a></li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a></li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a></li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div><div class="p4"><h2>Provided for</h2><div id="cL"><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2013.  All rights reserved.</a></p><p><a href="http://www.medicinescomplete.com/mc/copyright.htm">MedicinesComplete © The Pharmaceutical Press 2013</a></p></div></div></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>